BRENNAN KEVIN M. (SVP, FINANCE AND ACCOUNTING) sold 22.3% of their position (1.83K shares) of XILIO THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/5/2026ACC: 0001193125-26-002518
Officer· SVP, FINANCE AND ACCOUNTING
Since Mar 2023
+93.39K
Net shares
Net buyer
$1.2K
Total sold
1
Open market trades
0B · 1S
4
Total transactions
100.22K acquired · 6.83K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
—
Trade value
—
% of position
156.4%
1/1/2026
3.20K→8.20K
Common Stock
Direct
Shares
−1.83K
Price / share
$0.64
Trade value
$1.17K
% of position
22.3%
1/2/2026
8.20K→6.37K
Total
Net shares
+3.17K
Net value
-$1.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/1/2026 | M · Option Exercise | +5K | — | — | 156.4% | 3.20K | 8.20K |
| Common Stock Direct | 1/2/2026 | S · Sale | −1.83K | $0.64 | $1.17K | 22.3% | 8.20K | 6.37K |
| Total | +3.17K | -$1.17K | ||||||
Derivative Transactions2
Stock Option (right to buy)
Direct
Converts to
Common Stock
95.22K shares
Shares
+95.22K
Strike price
0.841
Held after
95.22K
Exercisable
—
12/31/2025
Restricted Stock Units
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
Held after
10K
Exercisable
—
1/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock95.22K shares | 12/31/2025 | A · Award | +95.22K | 0.841 | — | 95.22K |
| Restricted Stock Units Direct | Common Stock5K shares | 1/1/2026 | M · Option Exercise | −5K | — | 10K |